Kenji Mishima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kenji Mishima has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
Junichi Tanaka
Division of Pathology, Department of Oral Diagnostic Sciences, Showa Medical University School of Dentistry, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan
13 shared publications- Junichi Tanaka
Division of Pathology, Department of Oral Diagnostic Sciences, School of Dentistry, Showa Medical University, Tokyo, Japan
12 shared publications Rika Yasuhara
Division of Pathology, Department of Oral Diagnostic Sciences, Showa University School of Dentistry, Tokyo, Japan
8 shared publications- Rika Yasuhara
Division of Pathology, Department of Oral Diagnostic Sciences, School of Dentistry, Showa University, Tokyo, Japan
8 shared publications Akane Yukimori
Division of Pathology, Department of Oral Diagnostic Sciences, Showa University School of Dentistry, Tokyo, 142-8555, Japan
5 shared publicationsKoki Takamatsu
Department of Oral Surgery, Showa University School of Dentistry, Tokyo, Japan
5 shared publications
Latest Publications
- 11 February 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100750
Oral biosciences: The annual review 2025
- 11 February 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100750
Oral biosciences: The annual review 2025
- 10 February 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100748
Inflammatory characteristics induced by cellular senescence in the junctional epithelium of aged mice
- 10 February 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100748
Inflammatory characteristics induced by cellular senescence in the junctional epithelium of aged mice
- 1 January 2026
- Published by Wiley in Oral Science International
- Vol. 23 (3)
Age‐Associated Changes in the Expression Level of Txnip in Submandibular Gland Acinar Cells Revealed by Single‐Cell RNA Sequencing
- 1 January 2026
- Published by Wiley in Oral Science International
- Vol. 23 (3)
Age‐Associated Changes in the Expression Level of Txnip in Submandibular Gland Acinar Cells Revealed by Single‐Cell RNA Sequencing
- Open Access
- 2 December 2025
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100721
Effects of Porphyromonas gingivalis-derived lipopolysaccharide on the barrier function of cultured junctional epithelial cells
- 2 December 2025
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100721
Open AccessEffects of Porphyromonas gingivalis-derived lipopolysaccharide on the barrier function of cultured junctional epithelial cells
- Open Access
Discovery of a Selective Inhibitor of ZIP14 with Therapeutic Potential for Cancer-associated Cachexia
ZIP14/SLC39A14, a membrane-bound metal transporter, is essential for systemic metal homeostasis and has been implicated in inflammatory and metabolic disorders, including cancer-associated cachexia. Despite its biological and therapeutic significance, no selective inhibitors have been identified. Here, we identify 1-phenyl-8-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-4-one (PPTD) as the first selective small-molecule inhibitor of ZIP14. PPTD efficiently blocks ZIP14-mediated uptake of zinc, iron, manganese, and cadmium, while sparing the closely related transporter ZIP8/SLC39A8. Mechanistically, PPTD binds specifically to a pocket formed at the dimer interface of ZIP14, as revealed by AlphaFold3 structural prediction, ligand–interaction profiling, structure–activity analyses, and site-directed mutagenesis, providing direct evidence for a targeted inhibition mechanism. ZIP14-driven metal influx promotes reactive oxygen species and lipid peroxidation, leading to cytotoxicity, which PPTD effectively reverses. In vivo , PPTD ameliorates major features of cancer cachexia in mice, including weight loss, reduced survival, muscle wasting, impaired locomotor activity, and disease progression. PPTD thus provides both a chemical probe to dissect ZIP14 function and a potential therapeutic candidate for cancer cachexia, establishing a foundation for the development of therapies targeting ZIP14-mediated metal dysregulation.
Open AccessDiscovery of a Selective Inhibitor of ZIP14 with Therapeutic Potential for Cancer-associated Cachexia
ZIP14/SLC39A14, a membrane-bound metal transporter, is essential for systemic metal homeostasis and has been implicated in inflammatory and metabolic disorders, including cancer-associated cachexia. Despite its biological and therapeutic significance, no selective inhibitors have been identified. Here, we identify 1-phenyl-8-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-4-one (PPTD) as the first selective small-molecule inhibitor of ZIP14. PPTD efficiently blocks ZIP14-mediated uptake of zinc, iron, manganese, and cadmium, while sparing the closely related transporter ZIP8/SLC39A8. Mechanistically, PPTD binds specifically to a pocket formed at the dimer interface of ZIP14, as revealed by AlphaFold3 structural prediction, ligand–interaction profiling, structure–activity analyses, and site-directed mutagenesis, providing direct evidence for a targeted inhibition mechanism. ZIP14-driven metal influx promotes reactive oxygen species and lipid peroxidation, leading to cytotoxicity, which PPTD effectively reverses. In vivo , PPTD ameliorates major features of cancer cachexia in mice, including weight loss, reduced survival, muscle wasting, impaired locomotor activity, and disease progression. PPTD thus provides both a chemical probe to dissect ZIP14 function and a potential therapeutic candidate for cancer cachexia, establishing a foundation for the development of therapies targeting ZIP14-mediated metal dysregulation.
- Open Access
- 17 June 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-3
Author Correction: Transcription factor FoxO1 regulates myoepithelial cell diversity and growth
- 17 June 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-3
Open AccessAuthor Correction: Transcription factor FoxO1 regulates myoepithelial cell diversity and growth
- 15 February 2025
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 67 (1) , 100631
Oral biosciences: The annual review 2024
- 15 February 2025
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 67 (1) , 100631
Oral biosciences: The annual review 2024
- Open Access
- 26 June 2024
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 66 (3) , 530-538
Exploring the role of DNMT1 in dental papilla cell fate specification during mouse tooth germ development through integrated single-cell transcriptomics and bulk RNA sequencing
- 26 June 2024
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 66 (3) , 530-538
Open AccessExploring the role of DNMT1 in dental papilla cell fate specification during mouse tooth germ development through integrated single-cell transcriptomics and bulk RNA sequencing
- Open Access
- 11 January 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-15
Transcription factor FoxO1 regulates myoepithelial cell diversity and growth
Salivary gland myoepithelial cells regulate saliva secretion and have been implicated in the histological diversity of salivary gland tumors. However, detailed functional analysis of myoepithelial cells has not been determined owing to the few of the specific marker to isolate them. We isolated myoepithelial cells from the submandibular glands of adult mice using the epithelial marker EpCAM and the cell adhesion molecule CD49f as indicators and found predominant expression of the transcription factor FoxO1 in these cells. RNA-sequence analysis revealed that the expression of cell cycle regulators was negatively regulated in FoxO1-overexpressing cells. Chromatin immunoprecipitation analysis showed that FoxO1 bound to the p21/p27 promoter DNA, indicating that FoxO1 suppresses cell proliferation through these factors. In addition, FoxO1 induced the expression of ectodysplasin A (Eda) and its receptor Eda2r, which are known to be associated with X-linked hypohidrotic ectodermal dysplasia and are involved in salivary gland development in myoepithelial cells. FoxO1 inhibitors suppressed Eda/Eda2r expression and salivary gland development in primordial organ cultures after mesenchymal removal. Although mesenchymal cells are considered a source of Eda, myoepithelial cells might be one of the resources of Eda. These results suggest that FoxO1 regulates myoepithelial cell proliferation and Eda secretion during salivary gland development in myoepithelial cells.
- 11 January 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-15
Open AccessTranscription factor FoxO1 regulates myoepithelial cell diversity and growth
Salivary gland myoepithelial cells regulate saliva secretion and have been implicated in the histological diversity of salivary gland tumors. However, detailed functional analysis of myoepithelial cells has not been determined owing to the few of the specific marker to isolate them. We isolated myoepithelial cells from the submandibular glands of adult mice using the epithelial marker EpCAM and the cell adhesion molecule CD49f as indicators and found predominant expression of the transcription factor FoxO1 in these cells. RNA-sequence analysis revealed that the expression of cell cycle regulators was negatively regulated in FoxO1-overexpressing cells. Chromatin immunoprecipitation analysis showed that FoxO1 bound to the p21/p27 promoter DNA, indicating that FoxO1 suppresses cell proliferation through these factors. In addition, FoxO1 induced the expression of ectodysplasin A (Eda) and its receptor Eda2r, which are known to be associated with X-linked hypohidrotic ectodermal dysplasia and are involved in salivary gland development in myoepithelial cells. FoxO1 inhibitors suppressed Eda/Eda2r expression and salivary gland development in primordial organ cultures after mesenchymal removal. Although mesenchymal cells are considered a source of Eda, myoepithelial cells might be one of the resources of Eda. These results suggest that FoxO1 regulates myoepithelial cell proliferation and Eda secretion during salivary gland development in myoepithelial cells.
- 22 December 2023
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 66 (1) , 82-89
Single-cell analysis reveals the transcriptional alterations in the submandibular glands of aged mice
- 22 December 2023
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 66 (1) , 82-89
Single-cell analysis reveals the transcriptional alterations in the submandibular glands of aged mice